Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DCTH Shares are up on positive Phase 3 results and APPY is up as well

|Includes:APPY, Delcath Systems, Inc. (DCTH)

Today on Market Summary Updates:

Shares of Delcath Systems, Inc. (NASDAQ:DCTH), traded on a huge volume and were up 30% in the pre-market to close the day at $12.93(19% up), after the company announced that its Phase III National Cancer Institute (NYSE:NCI)-led multi-center clinical trial has successfully met the study's primary endpoint of extended hepatic progression-free survival in patients suffering from melanoma metastases in the liver.

TapeBeat profiled DCTH on Monday, 29 March 2010 (Read Here) and expected positive results with a bullish view on the stock when the price was in the $6 range.  The stock price today exceeded our expectations.


APPY: Shares of AspenBio Pharma (NASDAQ:APPY) have been trading at a higher than normal volume and the stock closed at $3.30(17% up) ahead of its data analysis for AppyScore(A Blood based diagnostic test for Appendicitis). The study completed patient enrollment on 03/23/2010 and expects the data analysis in 6-8 weeks(May 4-18).

Stocks: DCTH, APPY